DERMAGNOSTIX

Biochemicals for use in industry and science, In particular oligonucleotides and antibodies for qualitatively and quantitatively determining the expression of biomarkers for detecting skin diseases, in particular for detecting psoriasis and atopic eczema and for distinguishing between psoriasis and atopic eczema, all for scientific and research use; Diagnostic kits for commercial and scientific purposes for detecting skin diseases, predominantly consisting of biochemical reagents, in particular containing oligonucleotides and antibodies for qualitatively and quantitatively determining the expression of biomarkers for detecting skin diseases, in particular for detecting psoriasis and atopic eczema and for distinguishing between psoriasis and atopic eczema, all for scientific and research use; Diagnostic agents other than for medical and veterinary purposes

Pharmaceuticals, In particular products for treating skin diseases, in particular for treating psoriasis and atopic eczema; Diagnostic preparations for medical purposes, in particular in the field of dermatology, in particular in the field of diagnosing skin diseases, in particular for diagnosing dermato-oncological diseases and for diagnosing inflammatory skin diseases, in particular for diagnosing psoriasis and atopic eczema and for distinguishing between psoriasis and atopic eczema, in particular containing oligonucleotides and antibodies

Scientific and industrial research in particular in the biochemical, diagnostic and pharmaceutical fields; Laboratory research services relating to pharmaceuticals, in particular in the field of dermatology, in particular in the field of diagnosing skin diseases, in particular for diagnosing dermato-oncological diseases and for diagnosing inflammatory skin diseases, in particular for diagnosing psoriasis and atopic eczema and for distinguishing between psoriasis and atopic eczema, all for scientific and industrial research purposes